Navigation Links
Amicus Therapeutics Announces Third Quarter 2007 Financial Results
Date:10/31/2007

CRANBURY, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company developing small molecule, orally-active pharmacological chaperones for the treatment of human genetic diseases, today announced financial results for the third quarter of 2007. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (GAAP), Amicus announced a net loss attributable to common stockholders per share of $0.46 for the three months ended September 30, 2007. On a non-GAAP basis, Amicus reported a net loss attributable to common stockholders per share of $0.41 for the three months ended September 30, 2007. As of September 30, 2007, cash, cash equivalents, and marketable securities totaled $119.4 million.

"We continue to be very pleased with the progress in all of our clinical programs and look forward to sharing the preliminary Phase II data from our lead programs for Amigal(TM) for Fabry disease and Plicera(TM) for Gaucher disease by yearend," stated John F. Crowley, CEO of Amicus Therapeutics.

Financial Results

On a reported basis, the net loss attributable to common stockholders for the three months ended September 30, 2007 was $10.3 million as compared to $11.7 million for the same period in 2006. On a non-GAAP basis, the net loss for the three months ended September 30, 2007 was $9.2 million as compared to $10.6 million and the same period in 2006. The Company recorded no revenues during these periods.

On a non-GAAP basis, research and development expense for the three months ended September 30, 2007, was $7.1 million, an increase of $0.9 million from $6.2 million for the three months ended September 30, 2006.

On a non-GAA
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Massachusetts (PRWEB) March 02, 2015 Outside ... services, today announced the addition of Debbie Casey as ... capabilities in the healthcare space. , Debbie ... most of which with Fresenius Medical Care North America ... leverage her extensive experience to work with Outside GC’s ...
(Date:2/27/2015)... British Columbia , Feb. 27, 2015   ... leader in synthetic biology, today announced it has entered ... (OSF), the pioneering agricultural company behind the Arctic ... Through the acquisition, Intrexon expands its food programs to ... convenient for consumers while providing economic benefit throughout the ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine”) (TSX: IMV), ... announced that the U.S. Food and Drug Administration ... and Phase I clinical trials of the DPX-Anthrax ... co-development agreement signed with Gilead Life Sciences. The ... the DPX-Survivac. , “We have been in talks ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 FamilyFarms Group ... General Manager of State Line Farms, received the 2015 ... a producer, under the age of 35, who has ... is an honor to win the Tomorrow's Top Producer ... who won the Top Producer Award and learning from ...
Breaking Biology Technology:Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... TaqPlus Long DNA polymerase to genotype,mice ... ,Cardiovascular Research Center, University of Cincinnati, Cincinnati, OH , ... using,long-distance PCR, whereby genomic DNA is isolated from mouse ... Long DNA,polymerase.* , , PCR is ...
... The first precast gels for automated sequencing and genetic ... Harry Osterman Mark,Vanek ,LI-COR Biotechnology Division , LI-COR ... automated DNA sequencing and genetic analysis. Stratagenes CastAway , ... and are,ready to load in less than 30 minutes. ...
... solopack Gold cells reduce the time and effort needed ... Amy Duncan Bruce,Jerpseth Alan Greener ,Stratagene ... , strain* in an easy-to-use, single-reaction format ... 9 transformants/g of,supercoiled DNA or the competent efficiency ...
Cached Biology Technology:Easily Amplify Genomic DNA with Long-Distance PCR 2Easily Amplify Genomic DNA with Long-Distance PCR 3Easily Amplify Genomic DNA with Long-Distance PCR 4Easily Amplify Genomic DNA with Long-Distance PCR 5Easily Amplify Genomic DNA with Long-Distance PCR 6Easily Amplify Genomic DNA with Long-Distance PCR 7CastAway Precast Gels for Rapid Automated DNA Sequence Analysis 2CastAway Precast Gels for Rapid Automated DNA Sequence Analysis 3CastAway Precast Gels for Rapid Automated DNA Sequence Analysis 4CastAway Precast Gels for Rapid Automated DNA Sequence Analysis 5XL10-Gold Cells Supplied in New Single-Reaction Format 2XL10-Gold Cells Supplied in New Single-Reaction Format 3XL10-Gold Cells Supplied in New Single-Reaction Format 4
(Date:1/22/2015)... ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform its shareholders ... Washington,s Department of Licensing, in the United States, awarded ... for driver,s licenses and identification cards to its subsidiary, Valid ... start in January 2015, with enrollment and card production starting ...
(Date:1/22/2015)... MELBOURNE, Fla. , Jan. 13, 2015  Today, ... wearable technology, launched its crowdfunding campaign on Fundable, ... accelerate the build of production capacity to meet ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... emit deadly venom from tentacles that can reach ten feet in ... been of interest to scientists and to the public. Yet little ... the animal tree of life. In a paper published November ... researchers Allen Collins, Bastian Bentlage and Cheryl Lewis Ames of the ...
... Scientists in China are reporting discovery of unusual liver ... long-standing mystery of why the hepatitis B virus (HBV) sexually ... been published online in ACS, Journal of Proteome Research ... and colleagues note that chronic hepatitis B seems to progress ...
... A new generation of "green" automobile tires that can ... their way through the research pipeline. The new tires could ... a car,s fuel economy. That,s the topic of the cover ... (C&EN) ACS, weekly newsmagazine. C&EN Senior Editor Alexander ...
Cached Biology News:Scientists unravel evolution of highly toxic box jellyfish 2Scientists unravel evolution of highly toxic box jellyfish 3
... of a series of media originally developed at ... al. for the large scale propagation of cells ... primarily used for the growth and maintenance of ... of viruses in these cell lines. One of ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (C7046) ... assistance. Mfr Desig: Corning ...
...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: